Cargando…

A Prospective Validation Study of Lung Cancer Gene Panel Testing Using Cytological Specimens

SIMPLE SUMMARY: The gold standard for genetic panel test samples is considered to be tissue specimens. However, in clinical practice, tissue specimens are often unavailable. Therefore, using an amplicon-based high-sensitivity next-generation sequencing panel test capable of measuring eight druggable...

Descripción completa

Detalles Bibliográficos
Autores principales: Morikawa, Kei, Kida, Hirotaka, Handa, Hiroshi, Inoue, Takeo, Saji, Hisashi, Koike, Junki, Nakamura, Seiji, Sato, Yoshiharu, Ueda, Yumi, Suzuki, Fumihiko, Matoba, Ryo, Mineshita, Masamichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367394/
https://www.ncbi.nlm.nih.gov/pubmed/35954448
http://dx.doi.org/10.3390/cancers14153784
_version_ 1784765790544723968
author Morikawa, Kei
Kida, Hirotaka
Handa, Hiroshi
Inoue, Takeo
Saji, Hisashi
Koike, Junki
Nakamura, Seiji
Sato, Yoshiharu
Ueda, Yumi
Suzuki, Fumihiko
Matoba, Ryo
Mineshita, Masamichi
author_facet Morikawa, Kei
Kida, Hirotaka
Handa, Hiroshi
Inoue, Takeo
Saji, Hisashi
Koike, Junki
Nakamura, Seiji
Sato, Yoshiharu
Ueda, Yumi
Suzuki, Fumihiko
Matoba, Ryo
Mineshita, Masamichi
author_sort Morikawa, Kei
collection PubMed
description SIMPLE SUMMARY: The gold standard for genetic panel test samples is considered to be tissue specimens. However, in clinical practice, tissue specimens are often unavailable. Therefore, using an amplicon-based high-sensitivity next-generation sequencing panel test capable of measuring eight druggable genes, we enrolled patients who underwent diagnostic procedures to evaluate analysis accuracy, nucleic acid yield, and quality using cytological specimens. Cytological specimens were suitable for both nucleic acid yield and specimen quality due to the ease of collection and processing. Cytological sample analysis detected gene mutations in 68.7% of lung adenocarcinomas, and these samples were consistent with companion diagnostic tests 99.5% of the time. Moreover, the allele frequency of gene mutations in cytological specimens showed a high correlation with tissue specimens. This is the first study to prospectively evaluate the feasibility of a lung cancer gene panel test using cytological specimens. ABSTRACT: Background: Genetic panel tests require sufficient tissue samples, and therefore, cannot always be performed. Although collecting cytological specimens is easier than tissue collection, there are no validation studies on the diagnostic accuracy of lung cancer gene panel tests using cytology samples. Methods: Using an amplicon-based high-sensitivity next-generation sequencing panel test capable of measuring eight druggable genes, we prospectively enrolled consecutive patients who underwent diagnostic procedures. We evaluated the analysis accuracy rate, nucleic acid yield, and the quality of cytological specimens under brushing, needle aspiration, and pleural effusion. We then compared these specimens with collected tissue samples. Results: In 163 prospectively enrolled cases, nucleic acid extraction and analysis accuracy was 100% in cases diagnosed with adenocarcinoma. Gene mutations were found in 68.7% of cases with 99.5% (95% CI: 98.2–99.9) concordance to companion diagnostics. The median DNA/RNA yield and DNA/RNA integrity number were 475/321 ng and 7.9/5.7, respectively. The correlation coefficient of the gene allele ratio in 64 cases compared with tissue samples was 0.711. Conclusion: The success of gene analysis using cytological specimens was high, and the yield and quality of the extracted nucleic acid were sufficient for panel analysis. Moreover, the allele frequency of gene mutations in cytological specimens showed high correlations with tissue specimens.
format Online
Article
Text
id pubmed-9367394
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93673942022-08-12 A Prospective Validation Study of Lung Cancer Gene Panel Testing Using Cytological Specimens Morikawa, Kei Kida, Hirotaka Handa, Hiroshi Inoue, Takeo Saji, Hisashi Koike, Junki Nakamura, Seiji Sato, Yoshiharu Ueda, Yumi Suzuki, Fumihiko Matoba, Ryo Mineshita, Masamichi Cancers (Basel) Article SIMPLE SUMMARY: The gold standard for genetic panel test samples is considered to be tissue specimens. However, in clinical practice, tissue specimens are often unavailable. Therefore, using an amplicon-based high-sensitivity next-generation sequencing panel test capable of measuring eight druggable genes, we enrolled patients who underwent diagnostic procedures to evaluate analysis accuracy, nucleic acid yield, and quality using cytological specimens. Cytological specimens were suitable for both nucleic acid yield and specimen quality due to the ease of collection and processing. Cytological sample analysis detected gene mutations in 68.7% of lung adenocarcinomas, and these samples were consistent with companion diagnostic tests 99.5% of the time. Moreover, the allele frequency of gene mutations in cytological specimens showed a high correlation with tissue specimens. This is the first study to prospectively evaluate the feasibility of a lung cancer gene panel test using cytological specimens. ABSTRACT: Background: Genetic panel tests require sufficient tissue samples, and therefore, cannot always be performed. Although collecting cytological specimens is easier than tissue collection, there are no validation studies on the diagnostic accuracy of lung cancer gene panel tests using cytology samples. Methods: Using an amplicon-based high-sensitivity next-generation sequencing panel test capable of measuring eight druggable genes, we prospectively enrolled consecutive patients who underwent diagnostic procedures. We evaluated the analysis accuracy rate, nucleic acid yield, and the quality of cytological specimens under brushing, needle aspiration, and pleural effusion. We then compared these specimens with collected tissue samples. Results: In 163 prospectively enrolled cases, nucleic acid extraction and analysis accuracy was 100% in cases diagnosed with adenocarcinoma. Gene mutations were found in 68.7% of cases with 99.5% (95% CI: 98.2–99.9) concordance to companion diagnostics. The median DNA/RNA yield and DNA/RNA integrity number were 475/321 ng and 7.9/5.7, respectively. The correlation coefficient of the gene allele ratio in 64 cases compared with tissue samples was 0.711. Conclusion: The success of gene analysis using cytological specimens was high, and the yield and quality of the extracted nucleic acid were sufficient for panel analysis. Moreover, the allele frequency of gene mutations in cytological specimens showed high correlations with tissue specimens. MDPI 2022-08-03 /pmc/articles/PMC9367394/ /pubmed/35954448 http://dx.doi.org/10.3390/cancers14153784 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Morikawa, Kei
Kida, Hirotaka
Handa, Hiroshi
Inoue, Takeo
Saji, Hisashi
Koike, Junki
Nakamura, Seiji
Sato, Yoshiharu
Ueda, Yumi
Suzuki, Fumihiko
Matoba, Ryo
Mineshita, Masamichi
A Prospective Validation Study of Lung Cancer Gene Panel Testing Using Cytological Specimens
title A Prospective Validation Study of Lung Cancer Gene Panel Testing Using Cytological Specimens
title_full A Prospective Validation Study of Lung Cancer Gene Panel Testing Using Cytological Specimens
title_fullStr A Prospective Validation Study of Lung Cancer Gene Panel Testing Using Cytological Specimens
title_full_unstemmed A Prospective Validation Study of Lung Cancer Gene Panel Testing Using Cytological Specimens
title_short A Prospective Validation Study of Lung Cancer Gene Panel Testing Using Cytological Specimens
title_sort prospective validation study of lung cancer gene panel testing using cytological specimens
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367394/
https://www.ncbi.nlm.nih.gov/pubmed/35954448
http://dx.doi.org/10.3390/cancers14153784
work_keys_str_mv AT morikawakei aprospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens
AT kidahirotaka aprospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens
AT handahiroshi aprospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens
AT inouetakeo aprospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens
AT sajihisashi aprospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens
AT koikejunki aprospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens
AT nakamuraseiji aprospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens
AT satoyoshiharu aprospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens
AT uedayumi aprospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens
AT suzukifumihiko aprospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens
AT matobaryo aprospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens
AT mineshitamasamichi aprospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens
AT morikawakei prospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens
AT kidahirotaka prospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens
AT handahiroshi prospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens
AT inouetakeo prospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens
AT sajihisashi prospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens
AT koikejunki prospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens
AT nakamuraseiji prospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens
AT satoyoshiharu prospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens
AT uedayumi prospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens
AT suzukifumihiko prospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens
AT matobaryo prospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens
AT mineshitamasamichi prospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens